Doxorubicin and chloroquine coencapsulated liposomes: Preparation and improved cytotoxicity on human breast cancer cells

Journal of Liposome Research

Volumn 22, Issue 3, 2012, Pages 245-253

  Qiu, Liyan ^a   Yao, Mingfei ^a   Gao, Menghua ^a   Zhao, Qinghe ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Chloroquine; Doxorubicin; Liposome; Multidrug resistance

Indexed keywords

CHLOROQUINE; DOXORUBICIN; LIPOSOME; PHOSPHATIDYLCHOLINE;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN TISSUE; PH; PRIORITY JOURNAL; SOYBEAN;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CHEMISTRY, PHARMACEUTICAL; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MCF-7 CELLS; MOLECULAR CONFORMATION; PARTICLE SIZE;

EID: 84865232245     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.684150     Document Type: Article

References (20)

1. Agrawal, P., Gupta, U., Jain, N. K. (2007). Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 28:3349-3359. (Pubitemid 46693974)
2. Cullis, P. R., Bally, M. B., Madden, T. D., Mayer, L. D., Hope, M. J. (1991). pH gradients and membrane transport in liposomal systems. Trends Biotechnol 9:268-272. (Pubitemid 121003120)
3. Fritze, A., Hens, F., Kimpfler, A., Schubert, R., Peschka-Suss, R. (2006). Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta 1758:1633-1640. (Pubitemid 44466698)
4. Gao, Y., Chen, L., Zhang, Z ., Chen, Y., Li, Y. (2011). Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/ iMDR1-pDNA complex nanoparticles. Biomaterials 32:1738-1747.
5. Gottesman, M. M., Fojo, T., Bates, S. E. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev 2:48-58. (Pubitemid 37328807)
6. Jabr-Milane, L. S., Van Vlerken, L. E., Yadav, S., Amiji, M. M. (2008). Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev 34:592-602.
7. Kievit, F. M., Wang, F. Y., Fang, C., Mok, H ., Wang, K., Silber, J. R., et al. (2011). Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release 152:76-83.
8. Liang, X., Mao, G., Ng, K. Y. (2004). Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J Colloid Interface Sci 278:53-62. (Pubitemid 39094475)
9. Malam, Y., Loizidou, M., Seifalian, A. M. (2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592-599.
10. Patel, N. R., Rathi, A., Mongayt, D., Torchilin, V. P. (2011). Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. Int J Pharm 416 296-299.
11. Qiu, L., Jing, N., Jin, Y. (2008). Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Int J Pharm 361:56-63.
12. Solomon, V. R., Lee, H. (2009). Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625:220-233.
13. Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., et al. (2009). Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci 37:300-305.
14. Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219-234. (Pubitemid 43336035)
15. Thierry, A. R., Rahman, A., Dritschilo, A. (1994). A new procedure for the preparation of liposomal doxorubicin: biological activity in multidrug-resistant tumor cells. Cancer Chemother Pharmacol 35:84-88. (Pubitemid 24356752)
16. Varkouhi, A. K., Scholte, M., Storm, G., Haisma, H. J. (2010). Endosomal escape pathways for delivery of biologicals. J Control Release 151:220-228.
17. Vemuri, S., Rhodes, C. T. (1994). Development and characterization of a liposome preparation by a pH-gradient method. J Pharm Pharmacol 46:778-783. (Pubitemid 24319159)
18. Vezmar, M., Georges, E. (2000). Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs. Biochem Pharmacol 59:1245-1252. (Pubitemid 30157887)
19. Wang, J., Goh, B., Lu, W., Zhang, Q., Chang, A., Liu, X. Y., et al. (2005). In vitro cytotoxicity of stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells. Biol Pharm Bull 28:822-828. (Pubitemid 40740648)
20. Zahedi, P., De Souza, R., Huynh, L., Piquette-Miller, M., Allen, C. (2010). Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer. Mol Pharm 8:260-269.